Filed: 8/14/2026ACC: 0001964437-26-000012
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $697.47M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$697.47M
Total AUM (reported)
47.13M
Total Shares
Allocation by class
COM$482.08M69.1%
COM NEW$69.31M9.9%
SPONSORED ADS$69.14M9.9%
SHS USD$38.78M5.6%
CLASS A ORD SHS$12.40M1.8%
COM SER A$11.44M1.6%
ORDINARY SHARES$9.50M1.4%
Portfolio Concentration
Top 3$234.23M33.6%
4–10$292.98M42.0%
11–25$170.25M24.4%
Top 3 weight
33.6%
Top 10 weight
75.6%
Voting Authority Distribution
Total shares with voting rights: 47.13M
Sole
Full voting authority
47.13M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
AMYLYX PHARMACEUTICALS INC
SOLEShares4.62M
TypeSH
Market value$83.05M
11.91%
Sole
4.62M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares2.92M
TypeSH
Market value$82.04M
11.76%
Sole
2.92M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares518.87K
TypeSH
Market value$69.14M
9.91%
Sole
518.87K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares852.91K
TypeSH
Market value$49.58M
7.11%
Sole
852.91K
Shared
0.00
None
0.00
IMMIX BIOPHARMA INC
SOLEShares4.66M
TypeSH
Market value$48.03M
6.89%
Sole
4.66M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.31M
TypeSH
Market value$45.44M
6.52%
Sole
1.31M
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares160.94K
TypeSH
Market value$38.78M
5.56%
Sole
160.94K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares370.32K
TypeSH
Market value$38.74M
5.55%
Sole
370.32K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares524.73K
TypeSH
Market value$38.38M
5.50%
Sole
524.73K
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares3.30M
TypeSH
Market value$34.03M
4.88%
Sole
3.30M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares6.97M
TypeSH
Market value$32.57M
4.67%
Sole
6.97M
Shared
0.00
None
0.00
MONOPAR THERAPEUTICS INC
SOLEShares311.98K
TypeSH
Market value$28.89M
4.14%
Sole
311.98K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares1.06M
TypeSH
Market value$23.49M
3.37%
Sole
1.06M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares1.05M
TypeSH
Market value$19.62M
2.81%
Sole
1.05M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares2.10M
TypeSH
Market value$12.40M
1.78%
Sole
2.10M
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
SOLEShares1.48M
TypeSH
Market value$11.44M
1.64%
Sole
1.48M
Shared
0.00
None
0.00
OCULIS HOLDING AG
SOLEShares684.88K
TypeSH
Market value$9.50M
1.36%
Sole
684.88K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares3.87M
TypeSH
Market value$7.85M
1.13%
Sole
3.87M
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares770.64K
TypeSH
Market value$7.85M
1.13%
Sole
770.64K
Shared
0.00
None
0.00
INVIVYD INC
SOLEShares8.39M
TypeSH
Market value$7.32M
1.05%
Sole
8.39M
Shared
0.00
None
0.00
ALTO NEUROSCIENCE INC
SOLEShares182.83K
TypeSH
Market value$4.82M
0.69%
Sole
182.83K
Shared
0.00
None
0.00
SATELLOS BIOSCIENCE INC
SOLEShares350K
TypeSH
Market value$2.72M
0.39%
Sole
350K
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares663.06K
TypeSH
Market value$1.78M
0.26%
Sole
663.06K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMYLYX PHARMACEUTICALS INCSOLE | COM | 4.62M | SH | $83.05M 11.91% | 4.62M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 2.92M | SH | $82.04M 11.76% | 2.92M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 518.87K | SH | $69.14M 9.91% | 518.87K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 852.91K | SH | $49.58M 7.11% | 852.91K | 0.00 | 0.00 |
IMMIX BIOPHARMA INCSOLE | COM | 4.66M | SH | $48.03M 6.89% | 4.66M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.31M | SH | $45.44M 6.52% | 1.31M | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 160.94K | SH | $38.78M 5.56% | 160.94K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 370.32K | SH | $38.74M 5.55% | 370.32K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 524.73K | SH | $38.38M 5.50% | 524.73K | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 3.30M | SH | $34.03M 4.88% | 3.30M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 6.97M | SH | $32.57M 4.67% | 6.97M | 0.00 | 0.00 |
MONOPAR THERAPEUTICS INCSOLE | COM NEW | 311.98K | SH | $28.89M 4.14% | 311.98K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 1.06M | SH | $23.49M 3.37% | 1.06M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 1.05M | SH | $19.62M 2.81% | 1.05M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 2.10M | SH | $12.40M 1.78% | 2.10M | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCSOLE | COM SER A | 1.48M | SH | $11.44M 1.64% | 1.48M | 0.00 | 0.00 |
OCULIS HOLDING AGSOLE | ORDINARY SHARES | 684.88K | SH | $9.50M 1.36% | 684.88K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 3.87M | SH | $7.85M 1.13% | 3.87M | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 770.64K | SH | $7.85M 1.13% | 770.64K | 0.00 | 0.00 |
INVIVYD INCSOLE | COM | 8.39M | SH | $7.32M 1.05% | 8.39M | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 182.83K | SH | $4.82M 0.69% | 182.83K | 0.00 | 0.00 |
SATELLOS BIOSCIENCE INCSOLE | COM | 350K | SH | $2.72M 0.39% | 350K | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 663.06K | SH | $1.78M 0.26% | 663.06K | 0.00 | 0.00 |